Market news

Oilfield services face spending and debt challenges, but TechnipFMC, Oceaneering and Core Laboratories show resilience and growth potential.

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Detailed price information for Core Laboratories Inc (CLB-N) from The Globe and Mail including charting and trades.

Core Laboratories stock looks cheaper after a 47.1% six-month selloff, but falling earnings and geopolitical pressure keep the near-term case cautious.

CLB's Q2 earnings top estimates despite lower revenues and profit as Production Enhancement strength offsets Reservoir Description weakness.

Core Laboratories Inc (CLB) reports strong production enhancement growth and share repurchases, while navigating Middle East conflict and revenue declines in reservoir description.

Core Laboratories (NYSE:CLB) reported second-quarter 2026 revenue of $124.6 million, up more than 2% from the prior quarter but down 4% from a year earlier, as stronger completion-product sales partly offset disruptions to its service business from conflicts in the Middle East and Russia-Ukraine. C

Moby summary of Core Laboratories N.V.'s Q2 2026 earnings call

Core Laboratories (CLB) delivered earnings and revenue surprises of +37.50% and -2.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Oilfield services company Core Laboratories (NYSE:CLB) fell short of the market’s revenue expectations in Q2 CY2026, with sales falling 4.3% year on year to $124.6 million. Its non-GAAP profit of $0.11 per share was 26.9% above analysts’ consensus estimates.

Oilfield services company Core Laboratories (NYSE:CLB) will be announcing earnings results this Wednesday afternoon. Here’s what investors should know.

Detailed price information for Core Laboratories Inc (CLB-N) from The Globe and Mail including charting and trades.

CLB's Q2 may reflect resilient international activity and tariff insulation, but weaker reservoir description results and higher costs could weigh.

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Detailed price information for Core Laboratories Inc (CLB-N) from The Globe and Mail including charting and trades.

Core Laboratories (CLB) has an average rating of Hold and mean price target of $15.50, according to

A number of stocks jumped in the afternoon session after President Trump declared the Iran ceasefire "over" and threatened fresh strikes, sending oil prices sharply higher and lifting the broad energy complex.